<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39384173</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2233-4521</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of preventive medicine and public health = Yebang Uihakhoe chi</Title><ISOAbbreviation>J Prev Med Public Health</ISOAbbreviation></Journal><ArticleTitle>Excess Deaths in Korea During the COVID-19 Pandemic: 2020-2022.</ArticleTitle><Pagination><StartPage>480</StartPage><EndPage>489</EndPage><MedlinePgn>480-489</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3961/jpmph.24.254</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Excess deaths, an indicator that compares total mortality rates before and during a pandemic, offer a comprehensive view of the pandemic's impact. However, discrepancies may arise from variations in estimating expected deaths. This study aims to compare excess deaths in Korea during the coronavirus disease 2019 pandemic using 3 methods and to analyze patterns using the most appropriate method.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Expected deaths from 2020 to 2022 were estimated using mortality data from 2015-2019 as reference years. This estimation employed 3 approaches: (1) simple average, (2) age-adjusted average, and (3) age-adjusted linear regression. Excess deaths by age, gender, and cause of death were also presented.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of excess deaths varied depending on the estimation method used, reaching its highest point with the simple average and its lowest with the age-adjusted average. Age-adjusted linear regression, which accounts for both the aging population and declining mortality rates, was considered most appropriate. Using this model, excess deaths were estimated at 0.3% for 2020, 4.0% for 2021, and 20.7% for 2022. Excess deaths surged among individuals in their 20s throughout the pandemic, largely attributed to a rise in self-harm and suicide. Additionally, the results indicated sharp increases in deaths associated with "endocrine, nutritional, and metabolic diseases" and "symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified."</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Substantial variations in excess deaths were evident based on estimation method, with a notable increase in 2022. The heightened excess deaths among young adults and specific causes underscore key considerations for future pandemic responses.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Im</LastName><ForeName>So-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Health and Medical Policy, Daegu City Hall, Daegu, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health, Graduate School of Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Ji-Yeon</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Kyungpook National University School of Medicine, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Duk-Hee</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Preventive Medicine, Kyungpook National University School of Medicine, Daegu, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>J Prev Med Public Health</MedlineTA><NlmUniqueID>101242972</NlmUniqueID><ISSNLinking>1975-8375</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Excess mortality</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pandemics</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Suicide</Keyword></KeywordList><CoiStatement>
<b>Conflict of Interest</b>
. The authors have no conflicts of interest associated with the material presented in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39384173</ArticleId><ArticleId IdType="pmc">PMC11471339</ArticleId><ArticleId IdType="doi">10.3961/jpmph.24.254</ArticleId><ArticleId IdType="pii">jpmph.24.254</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Joffe AR. COVID-19: rethinking the lockdown groupthink. Front Public Health. 2021;9:625778. doi: 10.3389/fpubh.2021.625778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.625778</ArticleId><ArticleId IdType="pmc">PMC7952324</ArticleId><ArticleId IdType="pubmed">33718322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP. Over- and under-estimation of COVID-19 deaths. Eur J Epidemiol. 202;36(6):581–588. doi: 10.1007/s10654-021-00787-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-021-00787-9</ArticleId><ArticleId IdType="pmc">PMC8318048</ArticleId><ArticleId IdType="pubmed">34322831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP, Zonta F, Levitt M. Flaws and uncertainties in pandemic global excess death calculations. Eur J Clin Invest. 2023;53(8):e14008. doi: 10.1111/eci.14008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.14008</ArticleId><ArticleId IdType="pmc">PMC10404446</ArticleId><ArticleId IdType="pubmed">37067255</ArticleId></ArticleIdList></Reference><Reference><Citation> Mathieu E, Ritchie H, Rodés-Guirao L, Appel C, Giattino C, Hasell J, et al. Coronavirus pandemic (COVID-19); 2020 [cited 2023 Feb 1]. Available from:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>Oh JH. Excess deaths during COVID-19, how much more have increased? KOSTAT Stat Plus. 2023;Summer:48–60. (Korean)</Citation></Reference><Reference><Citation>Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 2023;613(7942):130–137. doi: 10.1038/s41586-022-05522-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05522-2</ArticleId><ArticleId IdType="pmc">PMC9812776</ArticleId><ArticleId IdType="pubmed">36517599</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513–1536. 
 https://doi.org/10.1016/S0140-6736(21) 02796-3
.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C, Jang H, Oh J. Excess mortality during the Coronavirus disease pandemic in Korea. BMC Public Health. 2023;23(1):1698. doi: 10.1186/s12889-023-16546-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16546-2</ArticleId><ArticleId IdType="pmc">PMC10474701</ArticleId><ArticleId IdType="pubmed">37660007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Kim S, Park E, Kim CY. Inequitable distribution of excess mortality during the COVID-19 pandemic in Korea, 2020. Epidemiol Health. 2022;44:e2022081. doi: 10.4178/epih.e2022081.</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2022081</ArticleId><ArticleId IdType="pmc">PMC10089707</ArticleId><ArticleId IdType="pubmed">36228674</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin MS, Sim B, Jang WM, Lee JY. Estimation of excess all-cause mortality during COVID-19 pandemic in Korea. J Korean Med Sci. 2021;36(39):e280. doi: 10.3346/jkms.2021.36.e280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2021.36.e280</ArticleId><ArticleId IdType="pmc">PMC8506417</ArticleId><ArticleId IdType="pubmed">34636505</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitt M, Zonta F, Ioannidis JP. Comparison of pandemic excess mortality in 2020-2021 across different empirical calculations. Environ Res. 2022;213:113754. doi: 10.1016/j.envres.2022.113754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.113754</ArticleId><ArticleId IdType="pmc">PMC9225924</ArticleId><ArticleId IdType="pubmed">35753371</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbiellini Amidei C, Fedeli U, Gennaro N, Cestari L, Schievano E, Zorzi M, et al. Estimating overall and cause-specific excess mortality during the COVID-19 pandemic: methodological approaches compared. Int J Environ Res Public Health. 2023;20(11):5941. doi: 10.3390/ijerph20115941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20115941</ArticleId><ArticleId IdType="pmc">PMC10252246</ArticleId><ArticleId IdType="pubmed">37297545</ArticleId></ArticleIdList></Reference><Reference><Citation> Microdata Integrated Service. Causes of death statistics [cited 2023 Feb 1]. Available from: Available from:  https://mdis.kostat.go.kr/dwnlSvc/ofrSurvSearch.do?curMenuNo=UI_POR_P9240 (Korean)</Citation></Reference><Reference><Citation> Aron J, Muellbauer J, Giattino C, Ritchie H. A pandemic primer on excess mortality statistics and their comparability across countries; 2020 [cited 2023 Feb 1]. Available from:  https://ourworldindata.org/covid-excess-mortality.</Citation></Reference><Reference><Citation>Lim S, Sohn M. How to cope with emerging viral diseases: lessons from South Korea’s strategy for COVID-19, and collateral damage to cardiometabolic health. Lancet Reg Health West Pac. 2023;30:100581. doi: 10.1016/j.lanwpc.2022.100581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2022.100581</ArticleId><ArticleId IdType="pmc">PMC9442269</ArticleId><ArticleId IdType="pubmed">36093123</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya J, Magness P, Kulldorff M. Understanding the exceptional pre-vaccination Era East Asian COVID-19 outcomes. Adv Biol Regul. 2022;86:100916. doi: 10.1016/j.jbior.2022.100916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2022.100916</ArticleId><ArticleId IdType="pmc">PMC9575551</ArticleId><ArticleId IdType="pubmed">36328937</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawano T, Kotera Y, Ozaki A, Murayama A, Tanimoto T, Sah R, et al. Underestimation of COVID-19 cases in Japan: an analysis of RT-PCR testing for COVID-19 among 47 prefectures in Japan. QJM. 2020;113(8):551–555. doi: 10.1093/qjmed/hcaa209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa209</ArticleId><ArticleId IdType="pmc">PMC7454847</ArticleId><ArticleId IdType="pubmed">32573730</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Huh IS, Lee J, Kang CR, Cho SI, Ham HJ, et al. Application of testing-tracing-treatment strategy in response to the COVID-19 outbreak in Seoul, Korea. J Korean Med Sci. 2020;35(45):e396. doi: 10.3346/jkms.2020.35.e396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e396</ArticleId><ArticleId IdType="pmc">PMC7683243</ArticleId><ArticleId IdType="pubmed">33230987</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Andraweera P, Elliott S, Mohammed H, Lassi Z, Twigger A, et al. Asymptomatic SARS-CoV-2 infection by age: a global systematic review and meta-analysis. Pediatr Infect Dis J. 2023;42(3):232–239. doi: 10.1097/INF.0000000000003791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003791</ArticleId><ArticleId IdType="pmc">PMC9935239</ArticleId><ArticleId IdType="pubmed">36730054</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda H, Seyama K, Ito K, Ai T, Nojiri S, Hori S, et al. SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Sci Rep. 2021;11(1):8380. doi: 10.1038/s41598-021-87688-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-87688-9</ArticleId><ArticleId IdType="pmc">PMC8052331</ArticleId><ArticleId IdType="pubmed">33863960</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka H, Togawa K, Katanoda K. Impact of the COVID-19 pandemic on mortality trends in Japan: a reversal in 2021? A descriptive analysis of national mortality data, 1995-2021. BMJ Open. 2023;13(8):e071785. doi: 10.1136/bmjopen-2023-071785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2023-071785</ArticleId><ArticleId IdType="pmc">PMC10476106</ArticleId><ArticleId IdType="pubmed">37652585</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi P. Covid-19: do many people have pre-existing immunity? BMJ. 2020;370:m3563. doi: 10.1136/bmj.m3563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3563</ArticleId><ArticleId IdType="pubmed">32943427</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray SM, Ansari AM, Frater J, Klenerman P, Dunachie S, Barnes E, et al. The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses. Nat Rev Immunol. 2023;23(5):304–316. doi: 10.1038/s41577-022-00809-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00809-x</ArticleId><ArticleId IdType="pmc">PMC9765363</ArticleId><ArticleId IdType="pubmed">36539527</ArticleId></ArticleIdList></Reference><Reference><Citation>Souilmi Y, Lauterbur ME, Tobler R, Huber CD, Johar AS, Moradi SV, et al. An ancient viral epidemic involving host coronavirus interacting genes more than 20,000 years ago in East Asia. Curr Biol. 2021;31(16):3504–3514. doi: 10.1016/j.cub.2021.05.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2021.05.067</ArticleId><ArticleId IdType="pmc">PMC8223470</ArticleId><ArticleId IdType="pubmed">34171302</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez CA, Li H, Phelps KL, Zambrana-Torrelio C, Wang LF, Zhou P, et al. A strategy to assess spillover risk of bat SARS-related coronaviruses in Southeast Asia. Nat Commun. 2022;13(1):4380. doi: 10.1038/s41467-022-31860-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-31860-w</ArticleId><ArticleId IdType="pmc">PMC9363439</ArticleId><ArticleId IdType="pubmed">35945197</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TT, Choo EM, Nakamura Y, Suzuki R, Shiina T, Shin-I T, et al. Pre-existing cross-reactive neutralizing activity against SARS-CoV-2 and seasonal coronaviruses prior to the COVID-19 pandemic (2014-2019) with limited immunity against recent emerging SARS-CoV-2 variants, Vietnam. Int J Infect Dis. 2024;139:109–117. doi: 10.1016/j.ijid.2023.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.11.008</ArticleId><ArticleId IdType="pubmed">37984763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzullo AM, Axfors C, Contopoulos-Ioannidis DG, Apostolatos A, Ioannidis JP. Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environ Res. 2023;216(Pt 3):114655. doi: 10.1016/j.envres.2022.114655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2022.114655</ArticleId><ArticleId IdType="pmc">PMC9613797</ArticleId><ArticleId IdType="pubmed">36341800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu S, Nam HJ, Jhon M, Lee JY, Kim JM, Kim SW. Trends in suicide deaths before and after the COVID-19 outbreak in Korea. PLoS One. 2022;17(9):e0273637. doi: 10.1371/journal.pone.0273637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0273637</ArticleId><ArticleId IdType="pmc">PMC9467344</ArticleId><ArticleId IdType="pubmed">36094911</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Sung HK, Kim T, Ko SK, Kim S, Lee JH. Trends in emergency department visits for suicide attempts before and during the COVID-19 pandemic in Korea: a nationwide study, 2016-2021. J Affect Disord. 2023;331:184–191. doi: 10.1016/j.jad.2023.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2023.03.037</ArticleId><ArticleId IdType="pmc">PMC10028213</ArticleId><ArticleId IdType="pubmed">36948463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto H, Ishikane M, Ghaznavi C, Ueda P. Assessment of suicide in Japan during the COVID-19 pandemic vs previous years. JAMA Netw Open. 2021;4(2):e2037378. doi: 10.1001/jamanetworkopen.2020.37378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.37378</ArticleId><ArticleId IdType="pmc">PMC7856546</ArticleId><ArticleId IdType="pubmed">33528554</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridge JA, Ruch DA, Sheftall AH, Hahm HC, O’Keefe VM, Fontanella CA, et al. Youth suicide during the first year of the COVID-19 pandemic. Pediatrics. 2023;151(3):e2022058375. doi: 10.1542/peds.2022-058375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2022-058375</ArticleId><ArticleId IdType="pmc">PMC10227859</ArticleId><ArticleId IdType="pubmed">36789551</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayed AA, El-Gendy AA, Aljohani AK, Haddad RA, Taher OH, Senan AM, et al. The effects of COVID-19 on the mental health of children and adolescents: a review. Cureus. 2024;16(3):e56473. doi: 10.7759/cureus.56473.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.56473</ArticleId><ArticleId IdType="pmc">PMC11025694</ArticleId><ArticleId IdType="pubmed">38638779</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo HG, Park S, Yon H, Lee SW, Koyanagi A, Jacob L, et al. National trends in sadness, suicidality, and COVID-19 pandemic-related risk factors among South Korean adolescents from 2005 to 2021. JAMA Netw Open. 2023;6(5):e2314838. doi: 10.1001/jamanetworkopen.2023.14838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.14838</ArticleId><ArticleId IdType="pmc">PMC10209749</ArticleId><ArticleId IdType="pubmed">37223902</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuntella O, Hyde K, Saccardo S, Sadoff S. Lifestyle and mental health disruptions during COVID-19. Proc Natl Acad Sci U S A. 2021;118(9):e2016632118. doi: 10.1073/pnas.2016632118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2016632118</ArticleId><ArticleId IdType="pmc">PMC7936339</ArticleId><ArticleId IdType="pubmed">33571107</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura S, Nishio M, Abe SK, Eguchi A, Inoue M, Suzuki M, et al. Impact of the COVID-19 pandemic on cancer death locations in Japan: an analysis of excess mortality through February 2023. J Epidemiol. 2024;34(7):349–355. doi: 10.2188/jea.JE20230235.</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20230235</ArticleId><ArticleId IdType="pmc">PMC11167266</ArticleId><ArticleId IdType="pubmed">37866926</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholey J, Karlinsky A, Kobak D, Tallack C. Conflicting COVID-19 excess mortality estimates. Lancet. 2023;401(10375):431–432. doi: 10.1016/S0140-6736(23)00116-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00116-2</ArticleId><ArticleId IdType="pmc">PMC9910840</ArticleId><ArticleId IdType="pubmed">36774147</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>